Taken from CNBC’s Daily Open, our international markets newsletter — Subscribe today UBS fourth-quarter profit rose 56% year on year to $1.2 billion, beating expectations. The Swiss bank on Wednesday also announced plans for a $3 billion share buyback in 2026 — but said it aims to exceed that target. Danish pharmaceutical giant Novo Nordisk , however, disappointed investors when it said Tuesday it expects sales and profit growth dropping this year . Following the surprise release — Novo was